Related Experiment Videos
[Hemorheologic applications in vascular surgery]
Insights
Conservative treatments like acetylsalicylic acid (ASA) and pentoxifylline support vascular surgery outcomes. Pentoxifylline showed better tolerability in preventing reocclusion after bypass surgery.
Area of Science:
- Vascular Surgery
- Pharmacology
Context:
- Vascular surgery addresses supraaortic, aortic aneurysm, and lower extremity obstructions.
- Conservative measures are crucial for preventing reocclusion, especially in complex cases.
Purpose:
- To review vascular surgery interventions and conservative reocclusion prevention strategies.
- To compare the efficacy and tolerability of acetylsalicylic acid (ASA) and pentoxifylline.
Summary:
- The study reviewed vascular interventions and conservative treatments including antiplatelet agents (ASA), hemorheological agents (pentoxifylline), and anticoagulation.
- A one-year study found no difference in patency rates between ASA and pentoxifylline for femoro-popliteal bypass surgery, but pentoxifylline was better tolerated.
Impact:
- Conservative treatments, alongside risk factor control and physical therapy, can significantly improve long-term vascular surgery outcomes.
- Pentoxifylline offers a well-tolerated alternative for reocclusion prevention in vascular surgery patients.
Abstract:
Possible vascular surgery interventions are reviewed in respect of the supraaortic segment (carotis obstruction), in aortic aneurysm, and in the lower extremities region (aorto-iliac/femoro-popliteal segment). The conservative therapeutic measures in terms of pre-, per-, and postoperative reocclusion prevention are discussed--also with a view to "surgically exhausted" cases--with special focus on platelet antiaggregants (acetylsalicylic acid [ASA]), hemorheological principles (hemodilution, pentoxifylline) and anticoagulation. In an one year comparative reocclusion prevention study of ASA and pentoxifylline (Trental 400) in patients with prosthetic bypass surgery in the femoro-popliteal segment no difference was found in respect of the patency rate between the two treatments, the hemorheological medication, however, proved significantly better tolerable. It can be concluded that such conservative treatments can clearly support the outcome of vascular surgery on the long run, with, indeed, control of risk factors and activation of patients to physical therapy (walking exercise).